Paul Treacy, SVP, Technical Operations at Jazz Pharmaceuticals plc (JAZZ), sold 1,413 shares at $131.97 ($186K) on 2017-03-06, disclosed to the SEC on 2017-03-08.
Open-market sale of $186k JAZZ by SVP, Technical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $131.97 | 355 | $47K | 25.1% |
| 2 | $131.97 | 529 | $70K | 37.4% |
| 3 | $131.97 | 529 | $70K | 37.4% |
| Total | $131.97 avg | 1,413 | $186K | 100% |
| Filing → |
| JAZZ | SELL | 2019-03-04 | $195K | — | Filing → |
| JAZZ | SELL | 2018-08-13 | $462K | — | Filing → |
| JAZZ | SELL | 2018-03-07 | $168K | — | Filing → |